Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASC: Restrictive vs Liberal Fluid Management in Sickle Cell Disease VOC
NCT07188766Recruiting
- Sponsor
- Imam Abdulrahman Bin Faisal University
- Start
- Oct 2025
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium chloride in vaso-occlusive crisis (VOC) (2 arms), sponsored by Imam Abdulrahman Bin Faisal University. Primary endpoint: Change in Pain intensity at 72 hours. Started Oct 2025; status: recruiting.
02
Drugs
sodium chloride
03
Conditions
vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT07188766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07188766.